Skip to Main Content

Paper Details

Outcomes of SOT Recipients With COVID-19 in Different Eras of COVID-19 Therapeutics.
Transplant Direct
11
2021
Acute kidney injury, COVID-19, allograft, convalescent plasma, coronavirus disease, dexamethasone, graft dysfunction, hypoxemic, patients, remdesivir
Author NameAffiliation
Alvin G ThomasJohns Hopkins University School of Medicine
Alvin G ThomasUniversity of North Carolina at Chapel Hill
Shmuel ShohamJohns Hopkins University School of Medicine
Evan M BlochJohns Hopkins University School of Medicine
Aaron A R TobianJohns Hopkins University School of Medicine
  • 1 - 5

Datasets

Release 1.2